T cell response against SARS-CoV-2 persists after one year in patients surviving severe COVID-19.
Venet F, Gossez M, Bidar F, Bodinier M, Coudereau R, Lukaszewicz AC, Tardiveau C, Brengel-Pesce K, Cheynet V, Cazalis MA, Pescarmona R, Garnier L, Ortillon M, Buisson M, Bouscambert-Duchamp M, Morfin-Sherpa F, Casalegno JS, Conti F, Rimmelé T, Argaud L, Cour M, Saadatian-Elahi M, Henaff L, Vanhems P, Monneret G; RICO study group.
Venet F, et al. Among authors: conti f.
EBioMedicine. 2022 Apr;78:103967. doi: 10.1016/j.ebiom.2022.103967. Epub 2022 Mar 27.
EBioMedicine. 2022.
PMID: 35349827
Free PMC article.